« Previous
Next »
Molecular Oncology
Volume 1, Issue 2
, Pages
196-204
, September 2007
Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer
-
Gene expression changes in the prostates of WT (non-transgenic), TRAMP water-fed and TRAMP mice treated with GTCs. Gene expression values were normalized, log2-transformed, and mean-centered to produc
Gene expression changes in the prostates of WT (non-transgenic), TRAMP water-fed and TRAMP mice treated with GTCs. Gene expression values were normalized, log2-transformed, and mean-centered to produce relative values. Each column represents pooled samples from three different prostate glands (dorsolateral) taken from WT, TRAMP water-fed and TRAMP treated with GTCs at the 12, 17, and 24
week time point. Some genes have multiple Affymetrix probe sets. Genes that are upregulated appear in red, and those that are downregulated appear in green. A color bar (bottom) relates to the intensity of the differences in gene expression. -
Immunohistochemical staining for MCM7 protein in the dorsolateral prostate of WT and TRAMP mice. (A) WT (non transgenic) mouse at 24weeks of age (20×); (B) TRAMP water-fed mouse at 12weeks of age (20×Immunohistochemical staining for MCM7 protein in the dorsolateral prostate of WT and TRAMP mice. (A) WT (non transgenic) mouse at 24
weeks of age (20×); (B) TRAMP water-fed mouse at 12
weeks of age (20×); (C) TRAMP water-fed mouse at 17
weeks of age (20×); (D) poorly differentiated prostate cancer in TRAMP water-fed mouse at 24
weeks of age (20×); (E) prostate section of a GTCs-fed TRAMP mouse at 17
weeks of age (20×); (F) prostate section of a GTCs-fed TRAMP mouse at 24
weeks of age. MCM7 is not detectable in the normal monolayer of epithelial cells of the gland (arrow) but specifically expressed in the multilayer and high grade PIN lesions (40×). -
Immunohistochemical staining for Ki-67 protein in the dorsolateral prostate of WT and TRAMP mice. (A) WT (non transgenic) mouse at 24weeks of age (20×); (B) TRAMP water-fed mouse at 12weeks of age (20Immunohistochemical staining for Ki-67 protein in the dorsolateral prostate of WT and TRAMP mice. (A) WT (non transgenic) mouse at 24
weeks of age (20×); (B) TRAMP water-fed mouse at 12
weeks of age (20×); (C) TRAMP water-fed mouse at 17
weeks of age (20×); (D) poorly differentiated prostate cancer in TRAMP water-fed mouse at 24
weeks of age (20×); (E) prostate section of a GTC-fed TRAMP mouse at 17
weeks of age (20×); (F) prostate section of a GTC-fed TRAMP mouse at 24
weeks of age (20×). -
Percentage of (A) MCM7 and (B) Ki-67 positive cells in the dorsolateral prostates of WT (non-transgenic), TRAMP water-fed and TRAMP treated with GTCs at 12, 17 and 24weeks. The mean values with standaPercentage of (A) MCM7 and (B) Ki-67 positive cells in the dorsolateral prostates of WT (non-transgenic), TRAMP water-fed and TRAMP treated with GTCs at 12, 17 and 24
weeks. The mean values with standard deviations were used to compare the percentage of positive cells for MCM7 and Ki-67 in each experimental group at the 12, 17 and 24
week time point. Values represent mean
±
SD of five animals in each group. *P
<
0.05; ***P
<
0.001 compared with aged-matched TRAMP water-fed mice. -
Western blot analysis of MCM7 protein levels in the dorsolateral prostates of 12, 17 and 24-week-old WT (non-transgenic), TRAMP water-fed and TRAMP treated mice with GTCs. Alpha-tubulin antibody was uWestern blot analysis of MCM7 protein levels in the dorsolateral prostates of 12, 17 and 24-week-old WT (non-transgenic), TRAMP water-fed and TRAMP treated mice with GTCs. Alpha-tubulin antibody was used to show equal loading of the protein samples. Western blot is a representative of one (pooled samples three mice per group) of three experiments performed. (B) Histogram indicates the ratio between MCM7 and α-tubulin obtained by densitometry analysis of the immunoblot. Data are presented as the mean
±
SD of three animals in each group. ***P
<
0.001 compared to TRAMP treated with GTCs at 17 and 24
weeks of age.
PII: S1574-7891(07)00039-7
doi: 10.1016/j.molonc.2007.05.007
© 2007 Federation of European Biochemical Societies. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Molecular Oncology
Volume 1, Issue 2
, Pages
196-204
, September 2007

